Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Journal of Neuro-Oncology|March 25, 2020
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastomaAndrew Song, Voichita Bar-Ad, Nina Martinez, et al.
American Journal of Clinical Oncology|April 12, 2019
Rapid Early Tumor Progression is Prognostic in Glioblastoma PatientsJoshua D Palmer, Deepak Bhamidipati, Gaurav Shukla, et al.
Dental Materials : Official Publication of the Academy of Dental Materials|May 27, 2019
Ionic liquid as antibacterial agent for an experimental orthodontic adhesiveIsadora Martini Garcia, Carolina Jung Ferreira, Virgínia Serra de Souza, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 9, 2021
Resected WHO grade I meningioma and predictors of local controlKamila Nowak-Choi, Joshua D Palmer, James Casey, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Pageof 24